ASX Announcement

Circadian's VGX-100 Well Tolerated in Phase 1 Clinical Trial

Published: 02/06/14, 09:51am (AEST)4 pages
Opthea Limited
OPT:ASXHealthcare

Recent OPT Announcements

Price Sensitive only